Belgium· BE-AMP-SAM660486-00
Lonquex 6 mg/0.6 ml
A lipegfilgrastim product containing lipegfilgrastim, registered in Belgium by Teva. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Lipegfilgrastim is registered in 12 of 19 countries.
Countries holding a registration under ATC L03AA14 (lipegfilgrastim), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Lipegfilgrastim · ATC L03AA14
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Lipegfilgrastim
- Manufacturer
- Teva
- Country
- Belgium (BE)
- ATC code
- L03AA14
- ATC class
- Lipegfilgrastim
- Defined daily dose
- 0.3 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb4623336
- be_apb7737166
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lipegfilgrastim in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLONQUEXTeva B.V., Haarlem
- IrelandLonquex 6 mg/0.6 ml solution for injectionTeva B.V.
- NorwayLonquexTeva B.V.
- PolandLonquexTeva B.V.
- SwedenLonquex 6 mg/0,6 ml Injektionsvätska, lösningTeva B.V.
- IcelandLonquexTeva B.V.*
- SpainLONQUEX 6 MG/0,6 ML SOLUCION INYECTABLETeva B.V.
- FinlandLonquexTeva B.V.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Lonquex
- Iceland · Lonquex
- Liechtenstein · Lonquex
- Norway · Lonquex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5d613fcb-dc99-4487-94cc-5cb30e53f601 GET /v1/drugs/5d613fcb-dc99-4487-94cc-5cb30e53f601?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Lonquex 6 mg/0.6 ml",
"name_fr": "Lonquex 6 mg/0.6 ml",
"name_nl": "Lonquex 6 mg/0.6 ml",
"amp_code": "SAM660486-00",
"strengths": [
"10.0000",
"10.0000",
"30.0000",
"30.0000"
],
"pack_count": 2,
"substances": [
"Lipegfilgrastim",
"Sodium Hydroxide",
"Sorbitol",
"Polysorbate 20"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Lipegfilgrastim",
"authorisation_numbers": [
"EU/1/13/856/004",
"EU/1/13/856/005"
]
}See everything about lipegfilgrastim.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.